This is a placebo controlled study comparing Rimonabant 5 mg per day for 90 days with placebo for the same period. Objective is to improve walking abilities of spinal cord injury individuals (incomplete lesions) and demonstrate that it is a safe treatment in spinal cord injury population.
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Adverse Events (Safety)
Timeframe: 120 days
Biochemical and urine analysis (safety)
Timeframe: 120 days
ECG (safety)
Timeframe: 120 days
Hospital Anxiety and Depression Scale (HAD) (safety
Timeframe: 120 days
Modified Ashworth Scale (safety)
Timeframe: 90 days
Penn Scale (safety)
Timeframe: 90 days
Pain numeric rating scale (safety)
Timeframe: 90 days
Questionnaire of falls (safety)
Timeframe: 120 days
6 min walking test (efficacy)
Timeframe: 90 days